The FDA has accepted a new drug application for Lodotra, from Horizon Pharma, being a modified delayed-release formulation of low-dose...
Horizon Pharma, Inc. announced that its Swiss subsidiary has signed an exclusive agreement with Mundipharma for the commercialization and distribution...
AstraZeneca has announced that Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets have been recommended for marketing authorisation in the...
• Secondary prevention of ischaemic stroke and transient ischaemic attacks either alone or in conjunction with aspirin. • An adjunct to oral anti-coagulation for prophylaxis of thromboembolism associated with prosthetic heart valves.
Treatment of adrenal insufficiency in adults.
Non insulin-dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.
Non-insulin dependent Diabetes mellitus (Type II) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.
Mizolastine is a long-acting H 1 -antihistamine indicated for the symptomatic relief of seasonal allergic rhinoconjunctivitis (hay fever), perennial allergic rhinoconjunctivitis and urticaria.
Prophylactic treatment of angina pectoris.